Related Experiment Videos
Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer
1German Cancer Research Center, Institute for Experimental Pathology, Heidelberg.
Abstract:
Increased dosage of cellular oncogenes resulting from amplification of DNA is a frequent genetic abnormality of tumor cells and the study of oncogene amplification has been paradigmatic for the usefulness of molecular genetic research in clinical oncology. Certain types of human tumors carry an amplified cellular oncogene at frequencies of up to 50-60%. Human neuroblastoma has been prototypic for the importance of oncogene amplification in tumorigenesis, and evidence is emerging that amplification may be an early event involved in a more malignant form of this cancer. It is unclear at which stage amplification plays a role in other cancers. Amplification of cellular oncogenes is a good predictor of clinical outcome in some human malignancies.
Insights
Oncogene amplification, a DNA abnormality in tumor cells, is common in many cancers. This genetic change can predict patient outcomes and may indicate a more aggressive cancer form, particularly in neuroblastoma.
Area of Science:
- Oncology
- Molecular Genetics
- Cancer Biology
Background:
- Gene amplification, leading to increased oncogene dosage, is a common genetic alteration in tumor cells.
- The study of oncogene amplification has significantly advanced molecular genetic research in clinical oncology.
- Certain human tumors exhibit amplified cellular oncogenes in up to 50-60% of cases.
Purpose of the Study:
- To investigate the role and significance of oncogene amplification in tumorigenesis and clinical outcomes.
- To highlight the prototypic importance of oncogene amplification in human neuroblastoma.
- To explore the stage at which amplification influences other cancer types.
Main Methods:
- Analysis of genetic abnormalities in tumor cells.
- Molecular genetic research techniques.
- Clinical outcome correlation with oncogene amplification.
Main Results:
- Human neuroblastoma serves as a key model for understanding oncogene amplification in cancer development.
- Amplification appears to be an early event in more malignant forms of neuroblastoma.
- Oncogene amplification is a significant predictor of clinical outcome in specific human malignancies.
Conclusions:
- Oncogene amplification is a crucial genetic abnormality in cancer with implications for disease progression.
- Further research is needed to elucidate the role of amplification in various cancer types.
- The predictive value of oncogene amplification for clinical outcomes underscores its importance in oncology.